MICRO THERAPEUTICS INC
10QSB, EX-27.1, 2000-11-13
LABORATORY ANALYTICAL INSTRUMENTS
Previous: MICRO THERAPEUTICS INC, 10QSB, 2000-11-13
Next: PRINTRONIX INC, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Balance
Sheet and Statement of Operations in Form 10-QSB for the nine months ended
September 30, 2000 and is qualified in its entirety by reference to such Form
10-QSB.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          13,109
<SECURITIES>                                         0
<RECEIVABLES>                                    1,161
<ALLOWANCES>                                      (10)
<INVENTORY>                                      1,637
<CURRENT-ASSETS>                                16,437
<PP&E>                                           3,826
<DEPRECIATION>                                 (1,820)
<TOTAL-ASSETS>                                  19,926
<CURRENT-LIABILITIES>                            2,235
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            10
<OTHER-SE>                                       6,054
<TOTAL-LIABILITY-AND-EQUITY>                    19,926
<SALES>                                          3,781
<TOTAL-REVENUES>                                 3,781
<CGS>                                            2,226
<TOTAL-COSTS>                                    9,722
<OTHER-EXPENSES>                                 (613)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 805
<INCOME-PRETAX>                                (8,358)
<INCOME-TAX>                                         1
<INCOME-CONTINUING>                            (8,359)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,359)
<EPS-BASIC>                                     (0.88)
<EPS-DILUTED>                                   (0.88)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission